Data as of Mar 07
| -0.28 / -1.22%|
The 4 analysts offering 12-month price forecasts for Sangamo BioSciences Inc have a median target of 21.50, with a high estimate of 22.00 and a low estimate of 20.00. The median estimate represents a -5.20% decrease from the last price of 22.68.
The current consensus among 5 polled investment analysts is to Buy stock in Sangamo BioSciences Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.